Open Access is an initiative that aims to make scientific research freely available to all. To date our community has made over 100 million downloads. It’s based on principles of collaboration, unobstructed discovery, and, most importantly, scientific progression. As PhD students, we found it difficult to access the research we needed, so we decided to create a new Open Access publisher that levels the playing field for scientists across the world. How? By making research easy to access, and puts the academic needs of the researchers before the business interests of publishers.
We are a community of more than 103,000 authors and editors from 3,291 institutions spanning 160 countries, including Nobel Prize winners and some of the world’s most-cited researchers. Publishing on IntechOpen allows authors to earn citations and find new collaborators, meaning more people see your work not only from your own field of study, but from other related fields too.
To purchase hard copies of this book, please contact the representative in India:
CBS Publishers & Distributors Pvt. Ltd.
www.cbspd.com
|
customercare@cbspd.com
The early twentieth century was a crucial period for the identification and biological-chemical-physical characterisation of vitamins. From then until now, many studies have attempted to clarify into detail the biological role of the vitamins in humans and their direct connection with certain diseases, either in a negative way (appearance of deficiency diseases due to vitamin deficiency) or a positive way (use of vitamins to treat diseases and/or to improve human health). The aim of this work is to analyse, from an integrative point of view, the information about vitamins and their effects on human health, and to identify direct correlations between these compounds and health. The effects of vitamins supplements on diet are also explored. The analysis of the results shows that it is impossible to establish robust and universal conclusions about the benefit of vitamin supplementation on human health beyond the prevention and/or treatment of deficiency states.
Department of Agrochemistry and Biochemistry, Faculty of Science, Biochemistry and Molecular Biology, University of Alicante, Spain
Manuel Reig García-Galbis
Department of Nursing, Faculty of Health Sciences, University of Alicante, Spain
Department of Nutrition, Faculty of Health Sciences, University of Atacama, Chile
Rosa María Martínez Espinosa*
Department of Agrochemistry and Biochemistry, Faculty of Science, Biochemistry and Molecular Biology, University of Alicante, Spain
*Address all correspondence to: rosa.martinez@ua.es
1. Introduction
Human nutrition, as a field of knowledge, had a great impact at the beginning of the twentieth century. From 1912, experiments such as those developed by English biochemist Frederick Hopkins (1861–1947) demonstrated the existence of certain organic substances in food that are essential for health. Hopkins called them ‘accessory food factors’ [1–3]. Shortly after that discoveries, the Polish biochemist Casimir Funk (1884–1967) proposed the term ‘vitamins’ to identify the substances previously termed ‘accessory food factors’ [2, 3]. The etymology of the term vitamin derives from the Latin ‘vita’ (life) and ‘amina’; Funk concluded that these substances were necessary for life and most of them contained an amino group [1, 4]. Thus, in the early sixties, the identification of essential nutrients necessary to support human life and health (macronutrients, micronutrients and trace elements) was almost concluded [4].
In the last half of last century, all vitamins were identified, their chemical structures were determined and natural sources from which vitamins can be obtained were described in detail. The biological role of each vitamin, their connections with several metabolic pathways and human pathologies and their importance in human nutritional processes were also quickly established [2, 4]. Besides, advances in chemical analysis/technologies during the last three decades have provided the tools to produce vitamins in vitro (even at large scale). Consequently, vitamins can be currently obtained by chemical synthesis, by isolation of natural sources (fat-soluble vitamins) or by microbial biotechnology (mainly water-soluble vitamins).
Thus, several human pathologies based on vitamins deficiency can be fully eradicated or their prevalence decreases substantially thanks to (i) promotion of good nutrition practices and (ii) use of dietary supplements containing mainly vitamins and trace elements. Even so, malnutrition is still a massive problem, particularly in some geographic regions characterised by poverty, poor nutrition understanding and practices and deficient sanitation and food security.
During the last five decades, several scientific-technical reports have confirmed and/or suggested new biological roles and properties for vitamins in human beings. Despite a large amount of existing information, there are very few integrative studies carried out on the effect of the vitamins on human health. In this sense, the work here presented summarises the main recent evidences that provide an integrated and updated analysis about the effect of vitamins in human health. The main aim is to understand how the use of vitamins (from food or from dietary supplements containing vitamins) can improve human health or the evolution of some specific disease.
Vitamins are organic micronutrients mainly synthesised by plants and microorganisms, which do not provide energy. Animals are not able to synthesise them, consequently, these essential micronutrients must be supplied by the diet in small amounts or even trace amounts (micrograms or milligrammes per day) for the maintenance of the metabolic functions of most animal cells [5, 6]. However, some vitamins can be synthesised in varying concentrations by humans. Thus, vitamin D and niacin are endogenously synthesised (in the skin by exposure to the sun or from the amino acid tryptophan, respectively) [7, 8]. On the other hand, vitamins such as K2, B1, B2 and biotin are synthesised by intestinal bacteria [9]. Generally, this endogenous synthesis is not enough to cover daily needs, so dietary intake is required [8, 10]. Most of the vitamins were identified related to the diagnosis of the diseases associated with their deficiency [2, 11]. Thus, these diseases are termed ‘deficiency diseases’.
Two groups of vitamins are distinguished based on their solubility (fat-soluble and water-soluble vitamins) [6] (Table 1). Each of these two groups exhibit significantly different physical-chemical-biological characteristics. The alphabetic nomenclature indicates the chronology of its discovery; however, the subsequent observation that vitamin B consisted of multiple compounds, gave rise to numerical nomenclature. The gaps in numbering are due to the removal of several substances that were initially described as vitamins [8, 10].
Fat-soluble vitamins
Water-soluble vitamins
Vitamin A or Retinol Vitamin D or Calciferol Vitamin E or α-Tocopherol Vitamin K or Phylloquinone
Vitamin B1 or Thiamine Vitamin B2 or Riboflavin Vitamin B3 or Niacin Vitamin B5 or Pantothenic acid Vitamin B6 or Pyridoxine Vitamin B7 or Biotin Vitamin B9 or Folic acid Vitamin B12 or Cobalamin Vitamin C or Ascorbic acid
Soluble in fats They do not contain nitrogen Require bile salts and fats for absorption Normally not excreted in the urine No daily or usual intake is required Hypervitaminosis can cause toxicity Liver and adipose tissue storage
Soluble in water They contain nitrogen (except vitamin C) Easily absorbed They present urinary excretion threshold (Unlikely toxicity) Almost daily intake is required Not stored in the body (Exception: vitamin B12 in liver)
Table 1.
Classification and differences of vitamins based on their solubility [6].
Note. Underlined: Name mainly used in the scientific literature.
Besides, vitamins are also classified by their biological role, which constitutes a more scientific approach to the current reality (Section 2.3 display details about the biological roles).
2.2. Physical-chemical properties
Each vitamin is a family of chemically related compounds that share qualitatively biological activities and may vary in aspects related to their bioactivity and bio assimilation. Therefore, the common name of the vitamin (i.e. vitamin A) is, in fact, a generic descriptor for all active analogues or relevant vitamin derivatives [12]. Table 2 summarises the main physical-chemical properties.
Vitamins play an important role in several metabolic pathways, acting closely associated with many of the enzymes that catalyse the reactions involved in these metabolic processes [10, 13, 14].
Using the ‘biological role’ as criteria, vitamins are classified into five groups:
Vitamins acting as coenzymes: B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine) and B7 (biotin).
Antioxidant vitamins: E (α-tocopherol) and C (ascorbic acid).
Vitamins showing hormonal functions: A (retinol) and D (calciferol)
Vitamins that act in the cellular proliferation: B9 (Folic acid), B12 (cobalamin).
The vitamins involved in coagulation: K or phylloquinone.
Thus, vitamins belonging to the group B work together at the cellular level and they are essential for neurological functioning and central metabolism [15]. A deficient intake of one or more than one of them may hinder the use of the other vitamins of group B. On the other hand, antioxidant vitamins protect against cell damage caused by the oxidative attack of free radicals reactive nitrogen species (ROS), Reactive nitrogen species (RNS), avoiding the destruction of the body’s tissues. This group of vitamins prevent the development of a large number of degenerative diseases, associated with ageing and oxidative stress, such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, cancer and myocardial infarction (heart attack), among others [16, 17]. In addition, some vitamins assume additional endocrine functions [18]. Consequently, the deficiency of a vitamin causes metabolic processes imbalances. This fact results in clinical signs or diseases of different health impact based on the level of deficiency. Table 3 summarises the main biological roles played by vitamins and anomalies in human health due to vitamin excess (toxic effects in the case of liposoluble vitamins) or vitamin deficiency.
Vitamin
Biological roles
Clinical signs of deficiency
Toxic effects
Vitamin A (retinol)
Cellular repair and maintenance. Immune response. Development of NS. Normal vision. Foetal development. Reproduction. Bone growth. Antioxidant activity.
Xerophthalmia, night blindness, keratinization of the corneal epithelium, dry mucous membranes
Fat and protein metabolism DNA and RNA synthesis Haemoglobin synthesis. Antibody production. Electrolyte balance. Neuronal function. Conversion of tryptophan to niacin
Neuropathy (paraesthesia). Epileptiform convulsions in infants. Hypochromic anaemia, seborrheic dermatitis and glossitis
Sensory neuropathy and skin disorders.
VitaminB7 (biotin)
Energy metabolism. Cell growth Fatty acids amino acids and glycogen synthesis
Dermatitis, conjunctivitis, alopecia and abnormalities of the CNS (depression, hallucinations and paraesthesia)
Not observed
Vitamin B9 (folic acid)
DNA and RNA synthesis Growth and cell division Leukocytes and erythrocytes formation and maturation. Folic acid metabolism
Macrocytic anaemia
Neurological complications in people with vitamin B12 deficiency
VitaminB12 (cobalamin)
Lipid and protein metabolism Red blood cells maturation. Iron absorption. DNA and RNA synthesis. Neuronal function
Hematologic (macrocytic anaemia), paraesthesia
Not observed
Vitamin C (ascorbic acid)
Multiple functions as coenzyme Iron absorption. Wound healing Antioxidant. Corticosteroid synthesis
Scurvy5. Sjögren syndrome, gum inflammation, dyspnoea, oedema y fatigue. Bone abnormalities, haemorrhagic symptoms and anaemia
Diarrhoea and other gastrointestinal disturbances
Table 3.
Main biological functions, clinical signs of deficiency and toxic effects (caused by excessive intake, hypervitaminosis) of vitamins [8, 10, 14, 18–20].
1First nutritional deficiency described, typical of populations subsisting on diets in which polished (‘white’) rice is the major food. The pathology leads to weight loss, heart disorders and neurological dysfunction.
2Affectation of the mucous membranes, tongue (glossitis), lips (cheilitis) and hypervascularization of the cornea.
3In populations subsisting on diets in which maize is the major food.
4Head and neck redness.
5Signs and symptoms include: follicular hyperkeratosis, petechial, ecchymosis, coiled broken hairs, swollen and bleeding gums, perifollicular bleeding, joint spasm, arthralgia and altered wound healing (IOM, [18]; Combs, [10]).
Most foods (exceptions: sucrose, refined grains and alcoholic beverages), provide vitamins in number and variable quantity [6]. However, there is not a single food containing all of them. Therefore, the diets must be mixed and balanced thus supplying the vitamins at the levels required by the body. When a food (or a diet) provides some or all the macronutrients but does not contain the necessary vitamins, it hinders the correct metabolism. Consequently, several official institutions around the world provide guides to recommend the optimum values of daily vitamins intake to promote health and to eradicate deficiency diseases.
The reference values of vitamin intake, allow preventing deficiency states and hypervitaminosis. Table 4 shows the recommended dietary allowance (RDA) related to vitamins, which are focused on metabolic needs in the general population, and the maximum tolerable daily intake (UL) without risk of adverse health effects for the general population. These may vary between countries.
Green vegetables, Brussel sprouts, cabbage, plant oils and margarine
Vitamin B1 (thiamine)
1.2 mg/d
-
Enriched, fortified or whole-grain products, bread and bread products, mixed foods whose main ingredient is grain, cereals, potatoes, liver, pork and eggs
Vitamin B2 (riboflavin)
1.2 mg/d
-
Organ meats, milk, bread products and fortified cereals
Vitamin B3 (niacin)
15 mg/d
35 mg/d
Meat, fish, poultry, enriched and whole grain breads and bread products, fortified cereals and mushrooms
*RDAs for vitamins A and D are listed in both International Units (IUs) and micrograms (mg/day) or micrograms (µg/day). The hyphen (-) indicates that the UL is not determined due to lack of data on the adverse effects associated with the excessive intake of these vitamins.
1 The vitamin A activity in foods is thus currently expressed as retinol equivalents (RE): 1 RE is defined as 1 µg of all-trans retinol, 6 µg of all-trans β-carotene, or 12 µg of another provitamin A carotenoids. Or it is expressed in IU (international units): 1 IU of vitamin A activity has been defined as equal either to 0.30 µg of all-trans retinol or to 0.60 µg of all-trans β-carotene.
2 In the case of vitamin D, 1 μg calciferol = 40 IU of vitamin D, a value based on a minimum of sun exposure.
Some vitamins can be supplied as provitamins, substances without vitamin activity that when metabolised, give rise to the formation of the corresponding vitamin [8, 12]. In some cases, it is possible to synthesise the vitamin from dietary compounds that apparently have no relation to it. For instance, nicotinic acid (vitamin B3) can be caused by the metabolic transformation of the amino acid tryptophan [8] or retinol (vitamin A), which can be obtained from beta-carotene (a pigment produced by some vegetables and microorganisms) [21].
4. Bibliographic and bibliometric analysis of the selected information.
To identify the main recent scientific-technical works about vitamins and their effect in human beings, a bibliographic/bibliometric review has been made following PRISMA guide [22]. The classical scheme proposed by Vilanova [23] has been used to analyse and to assess the quality of the information obtained. The main aim of this analysis is to understand how the use of vitamins (from food or from dietary supplements containing vitamins) can improve human health or the evolution of some specific diseases.
To do the information search (manuscripts published during the last 27 years in English and Spanish), general and more specific databases were selected (https://scholar.google.es/; PubMed, http://www.ncbi.nlm.nih.gov/pubmed; Scopus, https://www.scopus.com/; Web of Science (WOS), https://apps.webofknowledge.com/). The keywords used to do the search were: all the names of the vitamins, ‘vitamins & human health’, ‘vitamins & biological roles’ and ‘deficiency diseases’. These terms were previously identified through the database ‘MeSH’ (medical subject heading) as suitable descriptors for the realisation of this work. Combinations of these keywords with the terms ‘diet’ and ‘nutrition’ were also used to identify as many sources as possible. All the following options were selected in the databases previously mentioned: ‘Title/Abstract’, ‘article’, ‘clinical trial’ and ‘review’. Search finished in December 2016, the 15th. The research questions used to do the search and to select the information were: What is new about the knowledge of the effect of vitamins on human health? Is human health improving when multivitamin complexes are used?
Figure 1 displays the results of the search just using the combination ‘vitamins & human health’. Thanks to this keywords combination, 99,990 publications were identified (32,363 Pubmed; 35,127 WOS; 32,500 Scopus). About 60–77% of these publications are research articles (most of them clinical trials), 13–24% reviews and 5–11% are proceedings. Most of the items consulted (85%) belong to the field of medicine, followed by the fields of biochemistry, genetics and molecular biology (15%). To carry out this work, all the items were analysed by the three authors paying special attention to reviews and clinical trials. As it can be concluded from this figure, the last decade was particularly productive in terms of a number of publications analysing the effect of vitamins in human health or the use of vitamins as part of a treatment against certain pathologies.
Figure 1.
Identification of publications of interest. Number of items reported in the last 27 years. Keywords: Vitamins & Human health.
To address the detailed analysis of the direct effects of vitamins in human health, described by each item identified (Figure 1), four categories or manuscripts were established: 1: experimental studies, clinical trials; 2: analytical observational studies (cohort studies; case-control studies); 3: Descriptive observational studies (series of cases; studies of incidence and prevalence); 4: Reviews, systematic reviews and/or meta-analysis. The main conclusions from this analysis are summarised in the following section.
5. New advances of the effect of the use of vitamins through the diet in human health as well as the treatment of several human diseases
From the database containing the publications of interest previously mentioned, 75% of them were analysed into detail to highlight what is new about the use of vitamins through the diet in human health as well as their use as part of the treatment of several human diseases. Most the publications analysed in this work suggest a possible effect of a vitamin (its derivatives, analogues or precursors), or combinations of vitamins in human health. However, the results presented in the majority these publications are not conclusive. Thus, most of them assume that it is not possible to attribute with certainty the effect observed due to inconsistencies in the design or implementation of the studies. In this sense, there are many aspects to discuss, which are following summarised:
The standard method of medical science to establish and to compare the effectiveness of a substance in human beings is the clinical trial [24]. However, despite having strict inclusion criteria, these studies present some features that can affect the results. Some of the main features that may influence the results are: genetic background and style of life of the patient; non-specific effects and bioavailability of the vitamin/molecule tested; selection of the mechanism of action of the molecule tested; validity of the biomarkers used to determine the effect of a compound; the sample size (population) and the duration of the study (especially critical when the pathological condition under study takes decades to develop). All these aspects should be taken into account when interpreting the clinical results; otherwise, the associations observed are inadequately estimated of causality, and consequently, a direct relationship between the administration of a vitamin and effect on human health cannot be properly established.
Observational studies are easier to perform in terms of methodology, but they lack the capacity to establish causality of phenomena.
The meta-analysis presents a high level of scientific evidence, especially the meta-analysis of randomised controlled trials [24]. Meta-analysis is characterised by the high size of the study population, and therefore, they show better clinical significance. However, as a disadvantage, they usually are not feasible due to the difficulties of finding trials with the homogeneous design.
Therefore, despite a large number of publications on the vitamins and the potential uses of multi/vitamin supplements, there is no scientific evidence of beneficial effects in human health, beyond the prevention and/or treatment of deficiency states.
In this sense, the supplementation of food, as well as strategies to improve nutritional practises, have contributed to the eradication of deficiency diseases [25–28]. The main biological functions, clinical signs of deficiency and toxic effects of vitamins described until the end of the last century were previously discussed in Section 2.3 (Table 3). Recently, new correlations between vitamins and human health have been proposed. Details about the best described correlations between the use of vitamins on human health are following summarised:
Vitamin A: Diet supplementation has a positive effect on the blindness and the morbid-mortality in preschool-age children living in developing countries (http://data.unicef.org/nutrition/vitamin-a.html). Since 1960, clinical trials have shown that the disorders caused by vitamin A deficiency in developing countries can be prevented with regular dose and this supplementation significantly reduces infant mortality [29–31]. In relation to the other observed associations between vitamin A and certain diseases (Table 5), the evidence obtained do not allow definitive conclusions on the potential benefits of supplementation.
Vitamin D: The role of vitamin D in bone health is probably one of the better-supported relationships (Tables 3 and 5). The ‘new’ properties related to vitamin D are closely linked to the biological function already described. Thus, several meta-analyses of randomised controlled clinical studies conclude that vitamin D supplementation reduces the risk of falls (derived from the bone fragility) in a 19%, the risk of hip fracture in an 18% and the risk of non-vertebral fractures in a 20% in older adults. The effect on the prevention of falls or fractures is reached using high doses of at least 700–1000 IU/day or at least 400 IU/day, respectively [32–35]. In addition, supplementation has been shown to have a beneficial effect on the balance and muscle strength [36]. The evidence-based clinical trials suggest that supplementation with vitamin D (1000 IU/day) helps to prevent falls and fractures in the elderly population. However, the studies are not exempt from limitations; in general, these studies were done using supplements of vitamin D combined with calcium, so the effect attributable specifically to the vitamin D is difficult to determine. In addition, in many cases the basal levels of vitamin D and/or calcium uptake is unknown (diet, exposure to the sun, supplements, etc.).
Vitamin B9: intervention trials with folic acid in pregnant women stated that the supplementation reduces the occurrence of neural tube defects (NTD) [37–39]. In USA for instance, the use of folic acid supplements was legally established by the end of 1990, which reduced significantly (20–27%) the prevalence of neural tube defects at birth [19]. Since then, the consumption of 400 µg/day of folic is recommended to women who want to conceive to prevent birth defects in the foetus [40, 41]. In relation to the other observed associations between folic acid and certain diseases (Table 5), the evidences obtained do not make possible to attribute potential benefits to supplementation. Besides, for all the statements about the supplementation with vitamins, there are studies that found negative evidence, including the two cases mentioned above (vitamin D and folic acid).
In relation to the other observed associations between individual vitamins and certain diseases (Table 5), the evidences do not clearly show direct effects of supplementation, either in a positive way (prevention of chronic diseases and/or improvement of human health) or negative (adverse effects linked to the excessive intake), due to the inadequate methodology of the existing studies [42]. There is a need for new designs of scientific studies to reach valid conclusions. These new designs should consider several aspects such as (i) the initial nutritional status of patients, (ii) the use of homogeneous groups, (iii) the use of control groups and (iv) control of the composition of the ingested food (as it often overestimates the amount of vitamin because it does not consider the bioavailability).
On the other hand, population differences based on genetics could have significant implications in terms of vitamins bio assimilation [43]. The biochemical individuality and the lack of margins for the safety of vitamins sustain the basic premise of the toxicology ‘the dose makes the poison’. To evaluate the therapeutic efficacy of a vitamin is essential to analyse the dose to be administered, the form of the vitamin used (solution, microencapsulated or crystallised), the source of the vitamin (synthetic or purified from natural sources), the bioavailability and the interaction of a specific vitamin with other nutrients.
Summarising, the analysis set out in this work shows that ‘new’ potential benefits have been attributable to several vitamins. However, most of them are not robustly supported by evidences. In addition, the analysis suggests that the information related to individual vitamins for the prevention and/or treatment of diseases is more consistent than that of a multivitamin complex. In this sense, a systematic review carried out in the USA concludes that the evidence is insufficient to support the use of multivitamin supplements to prevent chronic degenerative diseases [42].
Finally, it is not surprising that numerous studies published in more than a decade have related some supplements (including vitamins E, C, D, A, and B) with adverse effects on human health. A meta-analysis of 67 trials showed that supplements of vitamin E, vitamin A and beta-carotene might be associated with a higher incidence of mortality [44]. Another study found a higher incidence (18%) of lung cancer and mortality from all causes (8%) in men who received beta-carotene [45]. In 2008, a large randomised controlled trial was stopped after reporting that supplementation of vitamin E and selenium resulted in an increase in the incidence of prostate cancer [46].
6. Use of multivitamin complexes and potential risk of hypervitaminosis
The rate of use of vitamins, minerals and other bioactive compounds available in food or dietary supplements is increasing significantly in advanced societies, especially in USA population, where the multivitamin complexes are the most commonly used supplements [47–49]. Several works state that currently, more than 47% of men and 59% of the women in the USA use supplements for health benefits, and the number of users is growing significantly [50]. In Europe, the greatest consumption was observed in the countries of the north, especially in Denmark (51.0% among men, 65.8% among women) [51].
There are reports indicating that there could be adverse effects on human health attributable to high consumption of multivitamin complexes. Almost 60,000 cases of toxicity by use of vitamins are reported annually USA poison control centres [http://www. aapcc.org/annual-reports/; [52]]. The most common adverse effects associated with excessive intake of vitamins (hypervitaminosis) are shown in Table 3, Section 2.3. Fat-soluble vitamins, for instance, due to its ability to accumulate in the body, have a greater potential for toxicity than water-soluble vitamins. However, the overdose of water-soluble vitamins can also cause toxicity affecting several body systems including the nervous system [20, 53]. Between the fat-soluble vitamins, the more toxic are vitamin A and vitamin D. The toxicity of vitamin A can be acute or chronic (IOM, 2006) and high doses cause many toxic manifestations (Table 3, Section 2.3). However, there has been no toxic effects of carotenoids (provitamin A), even when eaten in large amounts for weeks or years [41, 54], except for an orange/yellow colouring of the skin [55]. Vitamin D is potentially toxic, especially to small children [56]. In comparison to vitamins A and D, vitamin E is the least toxic when ingested orally [57]. In the case of vitamin K, toxic effects have not been observed even intaking large amounts over a long period [41]; however, a synthetic form of Vitamin K (menadione) has been associated with liver damage, and therefore no longer used therapeutically [18, 41].
The evidence on the safety profile of multivitamin complexes in humans has been established through case reports. However, the data reported from these case reports do not allow the accurate identification of maximum tolerable intake level (U). Besides, the toxicological data show that the margins of safety for multivitamin complexes intake are not yet defined, noting toxic doses significantly different in the scientific literature. This suggests that high doses of vitamins, especially of fat-soluble vitamins, should not be given to any group of the population until the safety of such doses is well established and based on scientific evidence.
Despite a large number of research works carried out to study the effects of vitamins in human health during the last decades, evidences to attribute potential benefits of vitamins supplementation on either human health or prevention and/or treatment of chronic degenerative diseases are still scarce. The analysis of the research works published during the last 27 years shows that it is impossible to establish robust and universal conclusions about the benefit of vitamin supplementation on human health beyond the prevention and/or treatment of deficiency states (stated during the second half of the twentieth century).
On the other hand, it is important to highlight the high heterogeneity in the clinical and methodological experiments as well as in the tools used to perform these studies, which contributes to making difficult a comparative analysis at large scale. Clinical trials of high methodological quality and a significant number of patients are yet to come. Due to these reasons, the widespread use of multivitamin complexes as diet supplements is still not fully justified.
The most prudent recommendation and scientifically supported for disease prevention is to eat a balanced diet with an emphasis on fruits and vegetables rich in antioxidants [58], since it is through the diet it is impossible to eat excessive quantities of vitamins. This approach minimises the risk of micronutrient deficiency or excess. However, not all individuals maintain a balanced diet for long periods of time. For this reason, certain circumstances (pregnant women, infants without breastfeeding, vegetarian individuals, elderly, etc.) may require the use of vitamin supplements under control to prevent deficiencies.
Although the potential of the vitamins in the promotion of human health is enormous, it is necessary to assess the risk/benefit ratio in each case. There is much more research to be done to understand the benefits of supplementation in the prevention of diseases and the improvement of human health. Accurate studies about consumption of vitamins by country (including aspects as sex, age, etc.) as well as about food fortification and vitamins protection and stabilisation are yet to come [28]. A greater knowledge in this area of the science of nutrition will have an impact on clinical practice dietetics and nutrition guidelines for public health.
1.Rosenfeld L. Vitamine—vitamin. The early years of discovery. Clinical Chemistry. 1997;43(4):680-685
2.Semba RD, Bloem MW. The anemia of vitamin A deficiency: Epidemiology and pathogenesis. European Journal of Clinical Nutrition. 2002;56(4):271-281. DOI: 10.1038/sj.ejcn.1601320
3.Maltz A. Casimer Funk, nonconformist nomenclature, and networks surrounding the discovery of vitamins. Journal of Nutrition. 2013;143(7):1013-1020. DOI: 10.3945/jn.112.171827
4.Varela G. Historia de las Vitaminas. En la alimentación y la nutrición a través de la historia. Salas J, Garcia P, Sanchez JM. ed. Barcelona: Glosa;2005. pp. 374-382
5.Mora JR, Iwata M y von Andrian UH. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nature Reviews Immunology. 2008;8(9):685-698. DOI: 10.1038/nri2378
6.Mataix J. Vitaminas I. Nutrición para Educadores. 2nd ed. Madrid: Diez de Santos; 2013:117-126
7.Nair R, Maseeh A. Vitamin D: The “sunshine” vitamin. Journal of Pharmacology and Pharmacotherapeutics. 2012;3(2):118-126
8.Bender DA. Nutritional Biochemistry of the Vitamins. 2nd ed. United Kingdom: Cambridge University Press; 2003. 470
9.Hill MJ. Intestinal flora and endogenous vitamin synthesis. European Journal of Cancer Prevention. 1997;6(1):43-45
10.Combs GF. The Vitamins: Fundamental Aspects in Nutrition and Health. 3rd ed. Burlington: Academic Press; 2008. 583
11.Piro A, Tagarelli G, Lagonia P, Tagarelli A, Quattrone A. Casimir Funk: His discovery of the vitamins and their deficiency disorders. Annals of Nutrition and Metabolism. 2010;57(2):85-88. DOI: 10.1159/000319165
12.Combs GF. The Vitamins: Fundamental Aspects in Nutrition and Health. 4th ed. London: Academic Press; 2012. pp. 33-70
13.Fidanza A, Audisio M. Vitamins and lipid metabolism. Acta Vitaminologica Et Enzymologica. 1982;4(1-2):105-114
14.Berg JM, Tymoczko JL, Stryer L. Biochemistry. 5th ed. New York: WH Freeman; 2002. Section 8.6. Available in: https://www.ncbi.nlm.nih.gov/books/NBK21154/
15.Kennedy DO. B Vitamins and the brain: Mechanisms, dose and efficacy—A review. Nutrients. 2016;8(2):68. DOI: 10.3390/nu8020068
16.Brambilla D, Mancuso C, Scuderi MR, Bosco P, Cantarella G, Lempereur L. The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: A point of view for an assessment of the risk/benefit profile. Nutrition Journal. 2008;7:29. DOI: 10.1186/1475-2891-7-29
17.Harrison FE, May JM. Vitamin C function in the brain: Vital role of the ascorbate transporter (SVCT2). Free Radical Biology & Medicine. 2009;46(6):719-730. DOI: 10.1016/j.freeradbiomed.2008.12.018
18.Institute of Medicine (IOM). Dietary references intakes: The essential guide to nutrient requirements. United States: The National Academies Press; 2006. 1344. Available in (access in February 2017): https://www.nal.usda.gov/sites/default/files/fnic_uploads/DRIEssentialGuideNutReq.pdf
19.Lanska DJ. Chapter 30: Historical aspects of the major neurological vitamin deficiency disorders: The water-soluble B vitamins. Handbook of Clinical Neurology. 2010b;95: 445-476. DOI: 10.1016/S0072-9752(08)02130-1
20.Hammond N, Wang Y, Dimachkie MM, Barohn RJ. Nutritional Neuropathies. Neurologic Clinics. 2013;31(2):477-489. DOI: 10.1016/j.ncl.2013.02.002
21.Tang G. Bioconversion of dietary provitamin A carotenoids to vitamin A in humans. The American Journal of Clinical Nutrition. 2010;91(5):1468-1473. DOI: 10.3945/ajcn.2010.28674G
22.Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Annals of Internal Medicine. 2015;162(11):777-784
23.Vilanova JC. Revisión bibliográfica del tema de estudio de un proyecto de investigación. Radiología. 2012;54(2):108-114
24.Baladie E, Basulto J. Sistema de clasificación de los estudios en función de la evidencia científica. Dietética y Nutrición Aplicada Basadas en la Evidencia (DNABE): una herramienta para el dietista-nutricionista del futuro. Act Diet. 2008;12(1):11-19. Available in (access in February 2017): http://fedn.es/docs/grep/docs/DNABE_2008.pdf
25.Hatun Ş, Ozkan B, Bereket A. Vitamin D deficiency and prevention: Turkish experience. Acta Paediatrica. 2011;100(9):1195-1199. DOI: 10.1111/j.1651-2227.2011.02383.x
26.Sherwin JC, Reacher MH, Dean WH, Ngondi J. Epidemiology of vitamin A deficiency and xerophthalmia in at-risk populations. Transactions of The Royal Society of Tropical Medicine and Hygiene. 2012;106(4):205-214. DOI: 10.1016/j.trstmh.2012.01.004
27.Swaminathan S, Thomas T, Kurpad AV. B-vitamin interventions for women and children in low-income populations. Current Opinion in Clinical Nutrition & Metabolic Care. 2015;18(3):295-306. DOI: 10.1097/MCO.0000000000000166
28.Dwyer JT, Wiemer KL, Dary O, Keen CL, King JC, Miller KB, et al. Fortification and health: Challenges and opportunities. Advances in Nutrition. 2015;6(1):124-131. DOI: 10.3945/an.114.007443
29.Lanska DJ. Chapter 29: Historical aspects of the major neurological vitamin deficiency disorders: Overview and fat-soluble vitamin A. Handbook of Clinical Neurology. 2010a;95:435-444. DOI: 10.1016/S0072-9752(08)02129-5
30.Mayo-Wilson E, Yakoob MY, Bhutta ZA. Vitamin A supplementation for preventing morbidity and mortality in children from 6 months to 5 years of age. The Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008524. DOI: 10.1002/14651858.CD008524.pub2. Review
31.Wilson EM, Imdad A, Herzer K, Yawar MY y Bhutta ZA. Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: Systematic review and meta-analysis. BMJ. 2011;343:d5094. DOI: https://doi.org/10.1136/bmj.d5094
32.Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, et al. Fall prevention with supplemental and active forms of Vitamin D: A meta-analysis of randomised controlled trials. BMJ. 2009;339:3692. DOI: 10.1136/bmj.b3692
33.Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials. Archives of Internal Medicine. 2009;169(6):551-561. DOI: 10.1001/archinternmed.2008.600
34.Michael YL, Whitlock EP, Lin JS, Fu R, O´Connor EA, Gold R. Primary care—Relevant interventions to prevent falling in older adults: A systematic evidence review for the U. S. Preventive services task force. Annals of Internal Medicine. 2010;153:815-825. DOI: 10.7326/0003-4819-153-12-201012210-00008
35.Murad MH, Elamin KB, Abu Elnour NO, Elamin MB, Alkatib AA, Fatourechi MM, et al. Clinical review: The effect of vitamin D on falls: A systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 2011;96(10): 2997-3006. DOI: 10.1210/jc.2011-1193. Epub 27 Jul 2011
36.Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: A systematic review and meta-analysis. Journal of the American Geriatrics Society. 2011;59:2291-2300. DOI: 10.1111/j.1532-5415.2011.03733.x
37.Stamm RA, Houghton LA. Nutrient intake values for folate during pregnancy and lactation vary widely around the World. Nutrients. 2013;5(10):3920-3947. DOI: 10.3390/nu5103920
38.Imbard A, Benoist JF, Blom HJ. Neural tube defects, folic acid and methylation. International Journal of Environmental Research and Public Health. 2013;10(9):4352-4389. DOI: 10.3390/ijerph10094352
39.Liew SC. Folic acid and diseases—Supplement it or not? Revista da Associação Médica Brasileira. 2016;62(1):90-100. DOI: 10.1590/1806-9282.62.01.90
40.Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. The New England Journal of Medicine. 1992;327(26):1832-1835. DOI: 10.1056/NEJM199212243272602
41.Institute of Medicine (IOM) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. Folate. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington: National Academies Press; 1998. 196-305. Available in: https://www.ncbi.nlm.nih.gov/pubmed/23193625
42.Huang HY, Caballero B, Chang S, Alberg AJ, Semba RD, Schneyer CR et al. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: A systematic review for a National Institutes of Health state-of-the-science conference. Annals of Internal Medicine. 2006;145(5):372-385. Available in: http://annals.org/aim/article/728199/efficacy-safety-multivitamin-mineral-supplement-use-prevent-cancer-chronic-disease
43.Kresevic DM, Denton JE, Burant CJ, Pallaki M. Racial difference in response to Vitamin D supplementation. Journal of the National Medical Association. 2015;107(2):18-24. DOI: 10.1016/S0027-9684(15)30020-1
44.Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. The Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007176. doi: 10.1002/14651858.CD007176. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD007176
45.Cardenas E, Ghosh R. Vitamin E: A dark horse at the crossroad of cancer management. Biochemical Pharmacology. 2013;86(7):845-852. DOI: 10.1016/j.bcp.2013.07.018
46.Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The selenium and vitamin E cancer prevention trial (SELECT). JAMA. 2009;301(1):39-51. DOI: 10.1001/jama.2008.864
47.NIH State-of-the-Science Panel. National Institutes of Health state-of-the-science conference statement: Multivitamin/mineral supplements and chronic disease prevention. The American Journal of Clinical Nutrition. 2007;85:257-264
48.Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J, et al. Dietary supplement use among U.S. Adults has increased since NHANES III (1988-1994). NCHS Data Brief. 2011;(61):1-8. Available in: http://www.cdc.gov/nchs/data/databriefs/db61.htm
49.Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, et al. Dietary supplement use in the United States, 2003-2006. Journal of Nutrition. 2011;141:261-266. DOI: 10.3945/jn.110.133025
50.Soni MG, Thurmond TS, Miller ER, Spriggs T, Bendich A, Omaye ST. Safety of vitamins and minerals: Controversies and perspective. Toxicological Sciences. 2010;118(2):348-355. DOI: 10.1093/toxsci/kfq293
51.Skeie G, Braaten T, Hjartåker A, Lentjes M, Amiano P, Jakszyn P, et al. Use of dietary supplements in the European prospective investigation into cancer and nutrition calibration study. European Journal of Clinical Nutrition. 2009;63(4):226-238. DOI: 10.1038/ejcn.2009.83
52.Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual report of the American association of poison control centers’ National Poison Data System (NPDS): 32nd Annual Report. Clinical Toxicology. 2015;53(10):962-1147. DOI: 10.3109/15563650.2015.1102927
53.Chawla J, Kvarnberg D. Hydrosoluble vitamins. Handbook of Clinical Neurology. 2014;120:891-914. DOI: 10.1016/B978-0-7020-4087-0.00059-0
54.Hathcock JN, Hattan DG, Jenkins MY, McDonald JT, Sundaresan PR, Wilkening VL. Evaluation of vitamin A toxicity. The American Journal of Clinical Nutrition. 1990;52(2):183-202
55.Bendich A. The safety of beta-carotene. Nutrition and Cancer. 1988;11(4):207-214. DOI: 10.1080/01635588809513989
56.Haussler MR, McCain TA. Basic and clinical concepts related to vitamin D metabolism and action. The New England Journal of Medicine. 1977;297:1041-50. DOI: 10.1056/NEJM197711102971906
57.Bendich A, Machlin LJ. Safety of oral intake of vitamin E. The American Journal of Clinical Nutrition. 1988;48(3):612-619
58.Lock K, Pomerleau J, Causer L, Altmann DR, McKee M. The global burden of disease attributable to low consumption of fruit and vegetables: Implications for the global strategy on diet. Bulletin of the World Health Organization. 2005;83(2):100-108. Available in: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2623811/
Written By
Noelia García Uribe, Manuel Reig García-Galbis and Rosa María
Martínez Espinosa
Submitted: 10 November 2016Reviewed: 11 April 2017Published: 02 August 2017
Open access peer-reviewed chapter
